+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses: Insights From TVT Registry



Case Volume and Outcomes After TAVR With Balloon-Expandable Prostheses: Insights From TVT Registry



Journal of the American College of Cardiology 73(4): 427-440



Given conflicting findings of previous studies, much remains to be understood regarding a volume-outcomes relationship (VOR) in transcatheter aortic valve replacement (TAVR). The purpose of this study was: 1) to determine if, after the initial learning curve (LC), a VOR for balloon-expandable (BE) TAVR persisted; and 2) to determine if LCs and VORs differed across different device generations. Data collected by the TVT registry for BE valve implants from November 2011 through January 2017 were included in this analysis (n = 61,949). Primary outcomes included 30-day all-cause mortality, stroke, and major vascular complications. For each center, all implants were ordered chronologically according to case sequence number (CS#). To determine where the learning curve terminated (LCT), a grid search analysis was applied across a range of CS# from 10 to 300 by increments of 1. After LCT, the VOR was assessed by examining case volume/month by center. This analysis was performed separately for: 1) all BE valve types; 2) Sapien 3 (S3) only; and 3) S3 in BE valve naïve sites. In experience with all commercially available BE valve types, there was an initial LC that terminates around case #201. After the initial LC, a volume-outcomes relationship was no longer evident. In analysis limited to S3, there was no demonstrable LC or VOR. Likewise, there was no demonstrable LC or VOR with S3 for BE valve naïve sites. After a case experience of 200 cases, there was LCT; subsequent to initial learning, a VOR was no longer evident. In the S3-only analysis, there was no LC or no demonstrable VOR. With current-generation BE-TAVR, centers should expect to achieve consistently excellent outcomes even during early case experience.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446668

Download citation: RISBibTeXText

PMID: 30704575

DOI: 10.1016/j.jacc.2018.11.031


Related references

TAVR with mechanically expandable prostheses: Is balloon aortic valvuloplasty really necessary?. International Journal of Cardiology 246: 37-40, 2018

Impact of Direct Transcatheter Aortic Valve Replacement Without Balloon Aortic Valvuloplasty on Procedural and Clinical Outcomes: Insights From the FRANCE TAVI Registry. Jacc. Cardiovascular Interventions 11(19): 1956-1965, 2018

Aortic Angulation Attenuates Procedural Success Following Self-Expandable But Not Balloon-Expandable TAVR. Jacc. Cardiovascular Imaging 9(8): 964-972, 2017

Early and mid-term outcomes of 1904 patients undergoing transcatheter balloon-expandable valve implantation in Italy: results from the Italian Transcatheter Balloon-Expandable Valve Implantation Registry (ITER). European Journal of Cardio-Thoracic Surgery 50(6): 1139-1148, 2016

Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: analysis of predictors and impact on long-term mortality: insights from the FRANCE2 Registry. Circulation 129(13): 1415-1427, 2014

TCT-103 National variation in post-TAVR antithrombotic therapy utilization and associated outcomes: Insights from the STS/ACC TVT Registry. Journal of the American College of Cardiology 66(15): B47-B48, 2015

Influence of sex on mortality and perioperative outcomes in patients undergoing TAVR: insights from the FRANCE 2 registry. Journal of the American College of Cardiology 65(7): 755-757, 2015

Procedural predictors of Post-TAVR Aortic Regurgitation for Balloon-expendable and Self-expendable devices? Insights from the France 2 registry. European Heart Journal 34(Suppl 1): 3760-3760, 2013

TCTAP A-162 Late Recoil of Balloon-expandable Transcatheter Aortic Bioprosthesis: Insights from the OCEAN-TAVI Registry. Journal of the American College of Cardiology 69(16): S85-S86, 2017

Comparison of outcomes using balloon-expandable versus self-expanding transcatheter prostheses according to the extent of aortic valve calcification. Clinical Research in Cardiology 106(12): 995-1004, 2017

Outcomes of patients at estimated low surgical risk undergoing transcatheter aortic valve implantation with balloon-expandable prostheses. Cardiovascular Revascularization Medicine 19(3 Pt A): 251-256, 2017

Predicting paravalvular leak after balloon-expandable TAVR. Catheterization and Cardiovascular Interventions 86(1): 152-153, 2016

Toward Precision in Balloon-Expandable TAVR: Oversizing Tight Versus Just Right. Jacc. Cardiovascular Interventions 10(8): 821-823, 2017

Vascular complication can be minimized with a balloon-expandable, re-collapsible sheath in TAVR with a self-expanding bioprosthesis. Catheterization and Cardiovascular Interventions 88(1): 135-143, 2017

Initial experience with the balloon expandable Edwards-SAPIEN Transcatheter Heart Valve in Australia and New Zealand: the SOURCE ANZ registry: outcomes at 30 days and one year. International Journal of Cardiology 170(3): 406-412, 2014